Rapid Formation of Epitaxial Oxygen Evolution Reaction Catalysts on Dendrites with High Catalytic Activity and Stability.

Oxygen evolution reaction is an essential but kinetically sluggish step in many energy storage and conversion processes and therefore is in pursuit of highly efficient and stable catalysts. Although nanosized transition-metal-based oxides/hydroxides exhibit high catalytic activity toward the oxygen evolution reaction (OER), many of them suffer from low stability at an anode current density in industrial scale. Herein, by combining a rapid epitaxial formation method with dynamic bubble-templated electrodeposition, we successfully developed single crystalline NiFeCu oxide catalysts with a hierarchical porous structure. It was found that the structure can facilitate fast electron transportation for the catalysts and retard the diffusion of the O atoms to the inner metallic current collector. The hierarchical pores inherited from the hydrogen bubble templates built ideal channels for the massive and rapid release of oxygen bubbles. As a consequence, the NiFeCu oxides catalyzed the OER more efficiently and steadily than the commercial RuO2 catalyst at an anode current density in industrial scale (300 mA/cm2). This work, by resolving the durability concerns for nanosized oxides, offers a series of highly efficient and stable catalysts for OER and a structure building strategy to boost the catalytic activity and stability for nonconductive catalysts.

Enhancing Oxygen Evolution Reaction Performance in Prussian Blue Analogues: Triple-Play of Metal Exsolution, Hollow Interiors, and Anionic Regulation.

Prussian blue analogs (PBAs) are promising catalysts for green hydrogen production. However, the rational design of high-performing PBAs is challenging, which requires an in-depth understanding of the catalytic mechanism. Here FeMn@CoNi core-shell PBAs are employed as precursors, together with Se powders, in low-temperature pyrolysis in an argon atmosphere. This synthesis method enables the partial dissociation of inner FeMn PBAs that results in hollow interiors, Ni nanoparticles (NPs) exsolution to the surface, and Se incorporation onto the PBA shell. The resulting material presents ultralow oxygen evolution reaction (OER) overpotential (184 mV at 10 mA cm-2 ) and low Tafel slope (43.4 mV dec-1 ), outperforming leading-edge PBA-based electrocatalysts. The mechanism responsible for such a high OER activity is revealed, assisted by density functional theory (DFT) calculations and the surface examination before and after the OER process. The exsolved Ni NPs are found to help turn the PBAs into Se-doped core-shell metal oxyhydroxides during the OER, in which the heterojunction with Ni and the Se incorporation are combined to improve the OER kinetics. This work shows that efficient OER catalysts could be developed by using a novel synthesis method backed up by a sound understanding and control of the catalytic pathway.

Controlled Self-Assembly of Hollow Core-Shell FeMn/CoNi Prussian Blue Analogs with Boosted Electrocatalytic Activity.

Prussian blue analogs (PBAs) are considered as efficient catalysts for energy-related applications due to their porous nanoscale architectures containing finely disseminated active sites. Their catalytic capability can be greatly boosted by the rational design and construction of complex PBA hybrid nanostructures. However, present-day structure engineering inevitably involves additional etchant or procedure. Herein, a facile, yet controllable one-pot self-assembly strategy is introduced to prepare hierarchical core-shell polymetallic PBAs (featuring bimetallic FeMn PBAs cores and CoNi PBAs shells) with hollow nano-cages/solid nano-cube architectures. The detailed characterization of material morphology/composition, assisted with theoretical simulations, reveals the underlying formation mechanism where the key factor is the control of the nucleation rate via the use of chelating agent (citrates) and reaction kinetics. The resulting FeMn@CoNi-H compound is found to accelerate the oxygen evolution reaction activity with a low overpotential (236 mV at a current density 10 mA cm-2 ) as well as a low Tafel slope (58.4 mV dec-1 ). Such an impressive performance is endowed by the rational compositional and structural design with optimized electronic structures as well as an increase in exposed active sites. This work provides a robust, cost-effective pathway that enables chemical and morphological control in creating high-performance catalysts for water electrolysis.

The potential pathogenic roles of S100A8/A9 and S100A12 in patients with MPO-ANCA-positive vasculitis.

BACKGROUND: The significance of S100A8/A9 and S100A12 in anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) has not been clarified. This study was dedicated to exploring the potential pathogenic roles of S100A8/A9 and S100A12 in patients with myeloperoxidase (MPO)-ANCA-positive vasculitis. METHODS: Serum and urine concentrations of S100A8/A9 and S100A12 of forty-two AAV patients were evaluated. The influence of S100A8/A9 and S100A12 on the chemotaxis, the apoptosis, the release of IL-1ß, the complement activation, the respiratory burst, as well as the neutrophil extracellular traps (NETs) formation of MPO-ANCA-activated neutrophils was investigated. RESULTS: The serum and urine S100A8/A9 and S100A12 of active MPO-AAV significantly increased (compared with inactive AAV and healthy controls, p < 0.001) and were correlated with the severity of the disease. In vitro study showed that S100A8/A9 and S100A12 activated the p38 MAPK/NF-κB p65 pathway, increased the chemotaxis index (CI) and the release of IL-1ß, extended the life span, and enhanced the complement activation ability of MPO-ANCA-activated neutrophils. The Blockade of TLR4 and RAGE inhibited the effects of S100A8/A9 and S100A12. All above-mentioned effects of S100A8/A9 and S100A12 were ROS-independent because neither S100A8/A9 nor S100A12 enhanced the ROS formation and NETs formation of MPO-ANCA-activated neutrophils. CONCLUSION: S100A8/A9 and S100A12 serve as markers for assessing the disease severity, and they may also play a role in MPO-AAV pathogenesis.

Molten Salt Synthesis of Broad-Band Near-Infrared InBO3:Cr3+ Submicron Phosphor and Its Luminescent Enhancement by Lanthanide Ion Codoping.

Phosphor materials with small particle sizes and high luminescent efficiency are desired for the fabrication of phosphor-converted light-emitting diodes (pc-LEDs). Near-infrared (NIR) pc-LED light sources have great application potential in the food industry and medical fields, which stimulate the extensive exploration of NIR phosphors. In this work, broad-band NIR-emitting InBO3:Cr3+ phosphors with submicron size and spherical morphology are successfully synthesized via the molten salt method. The InBO3:Cr3+ phosphor exhibits a broad emission band covering 700-1000 nm and peaking at ∼820 nm. The maximum emission intensity is obtained for InBO3:0.02Cr3+ with an internal quantum yield (IQY) of ∼62%, which is higher than that of microsized counterparts derived from solid-state reaction. Furthermore, the absorption and emission enhancements are achieved by codoping lanthanide ions into InBO3:Cr3+ submicron phosphors. The codoping of inert La3+ ions can increase the absorption efficiency of InBO3:Cr3+, due to the increased octahedral distortion of Cr3+ sites. The codoping of active Yb3+ ions can significantly enhance the NIR emissions of InBO3:Cr3+ between 950 and 1100 nm. Meanwhile, the increased IQY of ∼73% is achieved for InBO3:0.02Cr3+,0.005Yb3+ simultaneously with suppressed thermal quenching, originating from the effective energy transfer from Cr3+ to Yb3+ ions.

Comparison of arthroscopic debridement and microfracture in the treatment of osteochondral lesion of talus.

Objective: This study was performed to compare the clinical effect of arthroscopic debridement vs. arthroscopic microfracture in the treatment of osteochondral lesions of the talus. Methods: We retrospectively reviewed patients with osteochondral lesion of talus who were admitted to our hospital from April 2020 to April 2021. The patients were divided into Group A (arthroscopic debridement group, n = 39) and Group B (arthroscopic microfracture group, n = 42), and the intraoperative details in the two groups were analyzed. The American Orthopaedic Foot and Ankle Society (AOFAS) score and visual analogue scale (VAS) score were compared between the two groups before surgery and at the last follow-up. Results: The postoperative AOFAS score (Group A, 40.9-82.26; Group B, 38.12-87.38), VAS score (Group A, 6.44-3.92; Group B, 6.38-2.05) significantly improved in both groups, but the improvement was significantly greater in Group B than in Group A (P < 0.05). Among all patients, the AOFAS and VAS scores of men aged ≤30 years and patients with a low body mass index (BMI) improved more significantly (P < 0.05). Conclusion: The arthroscopic microfracture for the treatment of osteochondral lesion of talus is superior to joint debridement in terms of improving ankle function, especially in relatively young men with a relatively low BMI.

Cardamonin Inhibited IL-1ß Induced Injury by Inhibition of NLRP3 Inflammasome via Activating Nrf2/NQO-1 Signaling Pathway in Chondrocyte.

In this study we investigated the role and mechanism of cardamonin on IL-1ß induced injury in OA. CHON-001 cells were treated with cardamonin and IL-1ß and transfected with silencing nuclear factor erythroid 2-related factor 2 (siNrf2). Cell viability was detected by Cell Counting Kit-8 assay and flow cytometer assay was utilized for cell apoptosis assessment. IL-6, IL-8, TNF-α and Nrf2 mRNA expression was tested by qRT-PCR. Western blot was employed to evaluate MMP-3, MMP-13, Collagen II, Nrf2, NQO-1, NLRP3, Caspase 1 and apoptosis-associated speck-like protein containing a caspase-1 recruitment domain (ASC) protein levels. In CHON-001 cells, IL-1ß suppressed cell viability and Collagen II level while promoting cell apoptosis and expression of pro-inflammatory cytokines (IL-6, IL-8, TNF-α), MMPs (MMP-3, MMP-13), NQO-1, and NLRP3 inflammasome (NLRP3, Caspase 1 and ASC), with no significant influence on Nrf2. Cardamonin reversed the effect of IL-1ß on cell viability, cell apoptosis, pro-inflammatory cytokines, MMPs, Collagen II, and NLRP3 inflammasome levels. In addition, cardamonin advanced Nrf2 and NQO-1 expression of CHON-001 cells. SiNrf2 reversed the function of cardamonin on IL-1ß-induced cell apoptosis and expression of pro-inflammatory cytokines, Nrf2, NQO-1, and NLRP3 inflammasome in chondrocytes. Taken together Cardamonin inhibited IL-1ß induced injury by inhibition of NLRP3 inflammasome via activating Nrf2/NQO1 signaling pathway in chondrocyte.

Preferentially oriented Ag-TiO2 nanotube array film: An efficient visible-light-driven photocatalyst.

Ag-TiO2 nanotube array films with the preferential orientation of crystals were fabricated on ITO glass by magnetron sputtering and anodization. Comprehensive characterization was performed to ascertain the composition and microstructure characteristics of thin films. The photocatalytic activities were evaluated through the reduction of hexavalent chromium (Cr2O72- (Cr (VI)) as a model compound under visible light irradiation. XRD and XPS studies reveal the development of preferred orientation along [001] in anatase TiO2 nanotubes by adjusting the Ag content during magnetron sputtering. Such unusual behavior is attributed to the minimization of anatase (001) surface energy assisted by Ag. The Ag-TiO2 nanotube arrays having preferred crystal orientation exhibit superior separation/transfer of photo-induced charges. Furthermore, the Ag-TiO2 nanotube arrays show improved absorption of visible light due to the SPR effect induced by Ag and the formation of heterojunction between the TNAs and Ag2O. TNA-3Ag exhibits the highest photocatalytic activities by removing 99.1 % Cr (VI) in 90 min under visible light illumination.

MDA19, a novel CB2 agonist, inhibits hepatocellular carcinoma partly through inactivation of AKT signaling pathway.

BACKGROUND: CB2 (cannabinoid receptor 2) agonists have been shown to exert anti-tumor activities in different tumor types. However, there is no study exploring the role of MDA19 (a novel CB2 agonist) in tumors. In this study we aimed to investigate the effects of MDA19 treatment on HCC cell lines, Hep3B and HepG2 and determine the relevant mechanisms. RESULTS: Cell proliferation analysis, including CCK8 and colony formation assays, indicated that MDA19 treatment inhibited HCC cell proliferation in a dose- and time-dependent manner. Flow cytometry suggested that MDA19 induced cell apoptosis and activation of mitochondrial apoptosis pathway. Transwell assay indicated that HCC cell migration and invasion were significantly inhibited by MDA19 treatment. Mechanism investigation suggested that MDA19 induced inactivation of AKT signaling pathway in HCC cells. In addition, we investigated the function of CB2receptor in HCC and its role in the anti-tumor activity of MDA19. By searching on Kaplan-Meier plotter ( http://kmplot.com/analysis/ ), we found that HCC patients with high CB2 expression had a better survival and CB2 expression was significantly associated with gender, clinical stages and race of HCC patients (P < 0.05). CB2 inhibited the progression of HCC cells and its knockdown could rescue the growth inhibition induced by MDA19 in HCC. Moreover, the inhibitory effect of MDA19 on AKT signaling pathway was also reversed by CB2 knockdown. CONCLUSION: Our data suggest that MDA-19 exerts an anti-tumor activity at least partly through inactivation of AKT signaling pathway in HCC. CB2 functions as a tumor suppressor gene in HCC, and MDA19-induced growth inhibition of HCC cells depends on its binding to CB2 to activate it. MDA-19 treatment may be a promising strategy for HCC therapy. REVIEWER: This article was reviewed by Tito Cali, Mohamed Naguib and Bo Chen.

Severe acute interstitial nephritis induced by valsartan: A case report.

RATIONALE: Angiotensin receptor blocker (ARB) can increase serum creatinine or potassium levels in patients with renal insufficiency, renal artery stenosis, heart failure or hypovolemia, but hardly cause severe kidney injury in patients without any risk factors. A case of severe acute interstitial nephritis (AIN) induced by valsartan was reported here. PATIENT CONCERNS: A 62-year-old female with nausea for 1 month and acute deterioration of kidney function for 2 weeks was admitted. She had a history of hypertension for 5 months and had taken valsartan 40 mg daily for 4 months. Although the valsartan had been stopped for 2 weeks, the serum creatinine continuously increased after admission. Kidney biopsy demonstrated the eosinophils infiltration in interstitium. DIAGNOSES: AIN induced by valsartan. INTERVENTIONS: The patient was treated with glucocorticoid. OUTCOMES: The serum creatinine decreased gradually and got back to normal level 5 months later. Then therapy of glucocorticoid was stopped. Renal artery stenosis was excluded by computed tomography angiography (CTA). LESSONS: Although valsartan-induced allergy has been reported previously, AIN was firstly recognized as a severe complication of this drug. We suggest when there is a ARB-associated continuous deterioration of kidney function for patients without renal insufficiency, renal artery stenosis, heart failure or hypovolemia, AIN should be thought of and therapy with glucocorticoid should be considered if necessary.

Broadband near-infrared light source derived from Cr3+-doped phosphors and a blue LED chip.

NIR-emitting YAl3(BO3)4:Cr3+/Yb3+ (YAB:Cr/Yb) and NaScSi2O6:Cr3+ (BSSO:Cr) phosphors were demonstrated as luminescent converters for broadband NIR phosphor-converted LEDs (pc-LEDs). YAB:Cr/Yb phosphors show emissions in 670-800 nm (Cr3+ emission) and 950-1050 nm (Yb3+ emission) upon excitation at 450 nm. In the BSSO host, Cr3+ ions occupy Sc3+ sites with relatively weak crystal field, and thus a broadband Cr3+ emission at longer wavelengths of 750-950 nm is found for BSSO:Cr phosphors. Moreover, temperature-dependent spectral studies indicate that both YAB:Cr/Yb and BSSO:Cr phosphors exhibit good thermal stability, and more than 80% of the initial emission intensities can be sustained at 150°C. A NIR pc-LED prototype was fabricated by integrating these two phosphors with a blue LED chip (∼450 nm), which generated a broadband emission in the NIR spectral range from 780 to 1050 nm. A NIR light output power of ∼26 mW was achieved at the injection current of 100 mA, with the corresponding energy conversion efficiency of ∼8.6%.

Human umbilical cord mesenchymal stem cells facilitate the up-regulation of miR-153-3p, whereby attenuating MGO-induced peritoneal fibrosis in rats.

MiRNAs contribute greatly to epithelial to mesenchymal transition (EMT) of peritoneal mesothelial cells (PMCs), which is a crucial step in peritoneal fibrosis (PF). In this study, we tried to profile whether miRNA expression differences exist after human umbilical cord mesenchymal stem cells (hUCMSCs) treatment in PF rats and investigate the possible role of miR-153-3p involved in anti-EMT process. We randomly assigned 34 rats into three groups: control group (Group Control), MGO-induced PF rats (Group MGO) and hUCMSCs-treated rats (Group MGO + hUCMSCs). MiRNA microarrays and real-time PCR analyses were conducted in three groups. α-SMA, Snail1 and E-cadherin expression were detected by Western blot. Luciferase reporter assays were used to detect the effects of miR-153-3p overexpression on Snai1 in rat peritoneal mesothelial cells (RPMCs). We identified differentially expressed miRNAs related to EMT, in which miR-153-3p demonstrated the greatest increase in Group MGO + hUCMSCs. Transient cotransfection of miR-153-3p mimics with luciferase expression plasmids resulted in a significant repression of Snai1 3'-untranslated region luciferase activity in RPMCs. These studies suggest that miR-153-3p is a critical molecule in anti-EMT effects of hUCMSCs in MGO-induced PF rats. MiR-153-3p might exert its beneficial effect through directly targeting Snai1.

Multifunctional Lanthanide-Doped Core/Shell Nanoparticles: Integration of Upconversion Luminescence, Temperature Sensing, and Photothermal Conversion Properties.

Multifunctional integration on single upconversion nanoparticles (UCNPs), such as the simultaneous achievement of imaging, sensing, and therapy, will be extremely attractive in various application fields. Herein, we demonstrated that single core/shell NaGdF4:Yb/Er-based UCNPs (<10 nm) with a highly Yb3+ or Nd3+ doped shell simultaneously exhibited good upconversion luminescence (UCL), temperature sensing, and photothermal conversion properties under 980 or 808 nm excitation, respectively. The spatial separation between the emission/sensing core and the heating shell was able to tailor the competition between the light and heat generation processes, and hence higher UCL efficiency and enhanced heating capability were achieved by introducing the rational core/shell design. Especially, Nd3+-sensitized core/shell nanoparticles were excitable to the laser at a more biocompatible wavelength of 808 nm, and hence the heating effect of water was greatly minimized. The heating and sensing capabilities of Nd3+-sensitized core/shell UCNPs with smaller sizes (<10 nm) were confirmed in aqueous environment under single 808 nm laser excitation, implying their promising applications in imaging-guided and temperature-monitored photothermal treatments.

Photoluminescence properties of a ScBO3:Cr3+ phosphor and its applications for broadband near-infrared LEDs.

The rapid extension of solid state lighting technologies offers the possibility to develop broadband near-infrared (NIR) phosphor-converted LEDs (pc-LEDs) as novel NIR light sources. In this paper, a new NIR-emitting phosphor ScBO3:Cr3+ was synthesized by a high temperature solid state reaction method. Phase structure, spectroscopic properties, luminescent lifetime, quantum yield, emitter concentration influences and thermal quenching behavior of ScBO3:Cr3+, as well as its applications for NIR pc-LEDs, were systematically investigated. ScBO3:Cr3+ phosphors exhibit a broad absorption band ranging from 400 to 530 nm, which matches well with the characteristic emission of the blue LED chip. Moreover, Cr3+ ions occupy the Sc3+ sites with relatively low crystal field strength in the ScBO3 host, and therefore ScBO3:Cr3+ phosphors show intense broadband emission peaking at ∼800 nm upon excitation at 460 nm, originating from spin-allowed 4T2 → 4A2 transition of Cr3+ ions. The optimum Cr3+ concentration was determined to be ∼2 mol% with a quantum yield of ∼65%. A broadband NIR pc-LED prototype device was fabricated by the combination of ScBO3:Cr3+ phosphors and a blue LED chip, which showed a maximum NIR light output power of ∼26 mW and a corresponding energy conversion efficiency of ∼7%. The results indicate the great potential of ScBO3:Cr3+ phosphors for applications in broadband NIR pc-LEDs.

Effectiveness of 125I seed implantation in the treatment of non-small cell lung cancer during R2 resection.

The aim of the present study was to investigate the effectiveness of 125I particle implantation during R2resection for non-small cell lung cancer (NSCLC). Data from 23 patients with NSCLC and macroscopic residual diseasefollowing surgery (R2 resection) between March 2010 and May 2014 were retrospectively analyzed. Among these patients, 12 patients [4 with T-residual disease (incomplete resection of primary tumor but complete dissection of regional lymph node), 8 with N-residual disease (complete resection of primary tumor but incomplete resection of metastatic regional lymph node)] underwent 125I particle implantation during the operation, while the other 11 (4 with T-residual disease and 7 with N-residual disease) received postoperative conventional radiotherapy. The local control rate, overall survival, and distant metastasis were evaluated. Additionally, the efficacy and safety of brachytherapy using 125I particle implantation during surgery for locally advanced NSCLC were investigated. The 23 patients were followed up for 3-40 months. For the 125I group, the 2-year local control rate was 100%, and the median survival time was 24 months. The 1-2-year survival rates were 83.3 and 58.33%, respectively. For the postoperative radiotherapy group, the median survival time was 12 months, andthe 1- and 2-year survival rates were 54.5 and 27.7%, respectively. No statistically significant difference in 2-year survival rates was detected between the two treatment groups, but the particle implantation group exhibited a higher survival rate trend. For patients with T-residual disease, the survival rate was higher for the 125I seed implantation group compared with the postoperative radiotherapy group. However, there was no significant difference in the rates of metastasis between the two groups for patients with N-residual disease. Therefore, intraoperative implantation of 125I particles during R2 resection of NSCLC may be a safer and more reliable method to reduce the local recurrence rate compared with conventional radiotherapy. Although not statistically significant, the overall survival rate of patients in the 125I seed implantation group was higher compared with the postoperative radiotherapy group.

Emission color tuning of core/shell upconversion nanoparticles through modulation of laser power or temperature.

Upconversion nanoparticles (UCNPs) are an excellent choice to construct security features against counterfeiting, owing to their unique NIR-to-VIS upconversion luminescence (UCL) characteristics. However, the application of upconversion materials is limited, due to their single and invariant emission colors. Herein, the temperature-dependent UCL properties of NaGdF4:Yb/Ho (or Tm) UCNPs in the solid state have been investigated. An anomalous UCL enhancement at higher temperatures has been demonstrated for these small-sized (<10 nm) UCNPs and the underlying mechanism is discussed herein. Meanwhile, effective UCL with tunable multicolor emissions has been realized by the rational incorporation of Ho3+ and Tm3+ emitters into a single nanostructure. The emission colors of these Ho/Tm co-doped Na(Gd,Yb)F4 UCNPs can be tuned by changing the laser power or temperature, due to the different spectral sensitivities of the Tm3+ and Ho3+ emitters to the excitation power density and temperature. The power- and temperature-responsive color shifts of these Ho/Tm co-doped UCNPs are favorable for immediate recognition by the naked eye, but are hard to copy, offering the possibility of designing more secure anti-counterfeiting patterns.

Enhancing the upconversion luminescence and photothermal conversion properties of ∼800nm excitable core/shell nanoparticles by dye molecule sensitization.

Upconversion nanoparticles capable of strongly absorbing photons in a wide spectral range are highly desired for practical applications. In this work, IR-806 dye was used to increase the light absorptivity of Nd3+/Yb3+/Er3+ tri-doped core/shell nanoparticles and then to enhance their upconversion luminescence under ∼800nm excitation. The IR-806 dye exhibited more efficient energy transfer to Nd3+ ions than to Yb3+ ions for subsequent upconversion emission due to the increased spectral overlap between the dye emission and Nd3+ absorption. The influence of the Nd3+ concentration in the shell and the dye/nanoparticle ratio on the dye-sensitization effect was also investigated. A maximum 28-fold overall enhancement in the emission intensity was achieved for NaYF4:Yb3+/Er3+@NaYF4:Yb3+/Nd3+ core/shell nanoparticles using dye sensitization. The dye-sensitized NaYF4:Yb3+/Er3+@NaYF4:Yb3+/Nd3+ core/shell nanoparticles also exhibited increased photothermal conversion capabilities and excellent temperature sensing properties, enabling their potential application in photothermal nanoheaters with real-time temperature monitoring under 808nm single beam excitation.

Myeloperoxidase-antineutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis developed from ANCA negative renal limited vasculitis: A case report.

RATIONALE: The relationship between antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) and ANCA-negative vasculitis has not been elucidated. PATIENT CONCERNS: A 64-year-old female with edema and proteinuria was admitted. A kidney biopsy indicated focal proliferative nephritis with crescents in 25% of glomeruli. Serum ANCA was negative. Eighteen months later, systemic symptoms emerged and acute kidney injury occurred. Serum ANCA against myeloperoxidase (MPO) turned positive. Repeated kidney biopsy showed more severe lesion than last time. Immunoglobulin (Ig)G was purified from serum obtained before the first kidney biopsy. Weak ANCA which could not be detected in serum was found in IgG. DIAGNOSES: MPO-ANCA-associated AAV developed from ANCA-negative renal-limited AAV. INTERVENTIONS: The patient was treated with glucocorticoid. OUTCOMES: The serum creatinine decreased to 2.17 mg/dL a week later. MPO-ANCA turned negative when re-examined 3 weeks later. No relapse has been observed during follow-up for 6 months. LESSONS: This is the first reported case about the spontaneous transformation from ANCA-negative renal-limited AAV to ANCA-positive systemic vasculitis. There might be a slow process of epitope spreading in the pathogenesis of disease. Physicians should try their best to detect the ANCA in the diagnose and treatment of ANCA-negative AAV.

Repeated iodine-125 seed implantations combined with external beam radiotherapy for the treatment of locally recurrent or metastatic stage III/IV non-small cell lung cancer: a retrospective study.

BACKGROUND: Recurrent or metastatic lung cancer is difficult to manage. This retrospective study aimed to assess the efficacy of repeated iodine-125 seed implantations combined with external beam radiotherapy (EBRT) for locally recurrent or metastatic stage-III/IV non-small cell lung cancer (NSCLC). METHODS: Eighteen previously treated stage-III/IV NSCLC patients with local or metastatic recurrences underwent 1-to-3 iodine-125 implantations. Six of these patients received palliative EBRT and six patients received combined chemotherapy using gemcitabine and cisplatin. Near-term treatment efficacy was evaluated 3 months after seed implantation by comparing changes in tumor size on computed tomography images; the evaluated outcomes were complete response, partial response, stable disease, and local tumor control rate. Long-term efficacy was assessed based on 1- and 2-year survival rates. RESULTS: Patients were followed up for 6 to 50 months. The overall (i.e., complete + partial) response rate was 87.4 %. The local control rates after the first, second, and third years were 94.1, 58.8 and 41.2 %, respectively. CONCLUSIONS: The results of this study demonstrated that repeated implantation of radioactive particles combined with EBRT is a safe treatment that effectively controlled local recurrence and metastasis of stage III/IV NSCLC.

Exploring the mechanism of non-small-cell lung cancer cell lines resistant to epidermal growth factor receptor tyrosine kinase inhibitor.

PURPOSE: Here we aimed to explore the possible mechanism and potential regulatory relationships in which the non.small.cell lung cancer. (NSCLC)-resisted epidermal growth factor receptor. (EGFR) tyrosine kinase inhibitor erlotinib. MATERIALS AND METHODS: GSE38310, the gene expression profiles of NSCLC cell lines treated with dimethylsulfoxide or erlotinib, including HCC827, ER3, and T15-2, were downloaded from Gene Expression Omnibus database and preprocessed by normalization. Basing on the regulatory relationships of transcriptional factors obtained from University of California Santa Cruz. (UCSC) database, the differentially expressed genes. (DEGs) were screened using limma package in R with. |logFC| >1 and P < 0.05, and regulatory networks of these DEGs were built with supervised inference of regulatory networks (SIRENE). Subsequently, differentially regulatory networks were compared basing on Limit Fold Change. (LFC) method. RESULTS: Totally 24,380 genes were obtained, 1,531 DEGs were identified in HCC827 cell lines, 37 DEGs in ER3 cell lines, 156 DEGs in T15-2 cell lines. After removing the redundancy genes, 1,575 differentially expressed genes were got at last. Basing on three regulatory networks of HCC827 cell lines, ER3 cell lines and T15-2 cell lies, sex-determining region Y (SRY).related high mobility group-box gene 9. (SOX9) and Suppressor of cytokine signaling 3 (STAT3) were identified by comparing with HCC827 and ER3 networks. And suppressor of cytokine signaling 5 B (STAT5B), early growth response-1 (EGR1) and STAT6 were obtained in comparison of HCC827 and T15-2 networks. CONCLUSIONS: The regulatory edges with remarkable changes between HCC827 and ER3, HCC827 and T15.2 included some transcription factors and genes. (e. g., STAT3 and SOX9). STAT3, SOX9, STAT5B, EGR1, and STAT6 might affect the resistance of NSCLC to erlotinib.